After three years of intensive collaboration, leading European experts in adult acute lymphoblastic leukemia (ALL) have published therapy recommendations for those suffering from this rare and aggressive cancer. One of the world’s largest ALL study groups is based at Frankfurt University Hospital. Its systematic studies have already helped significantly increase the cure rate of those affected.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/cDPmJ1G